China CAS:28721-07-5 Manufacturers, Suppliers and Factory - Humanwell
English
Home > Products > CAS:28721-07-5

China CAS:28721-07-5 Manufacturer

We not only will try our greatest to offer superb companies to just about every buyer, but also are ready to receive any suggestion offered by our shoppers for CAS:28721-07-5, We are going to do our best to fulfill your specifications and are sincerely searching forward to building mutual valuable organization romantic relationship along with you!
CAS:28721-07-5, Welcome to visit our company and factory, there are various solutions displayed in our showroom that will meet your expectation, meanwhile, if you are convenient to visit our website, our sales staff will try their efforts to deliver you the best service

Related Products

Hot Products

  • Dutasteride

    Dutasteride

    Dutasteride has EP, USP, CP, IP, JP specification. CEP and FDA available.

    CAS:164656-23-9

  • Nintedanib Esylate

    Nintedanib Esylate

    Nintedanib Esylate has in-house specification. DMF available.

    CAS:656247-18-6

  • Megestrol Acetate

    Megestrol Acetate

    Megestrol acetate has CP, EP and USP specifications. DMF under filing.

    CAS:595-33-5

  • 16alpha-Hydroxyprednisolone

    16alpha-Hydroxyprednisolone

    16alpha-Hydroxyprednisolone has DMF available.

    CAS:13951-70-7

  • Cariprazine hydrochloride

    Cariprazine hydrochloride

    Cariprazine hydrochloride has In-house specification. DMF approved.

    CAS:1083076-69-0

  • Mifepristone Tablets

    Mifepristone Tablets

    Mifepristone Tablets Specifications：10mg*1
    Indications：Emergency Contraceptive
  • Related Blog
  • Reviews

  • 2019 CPhI China Exhibition Shanghai

    June 2019
    CPhI is the undisputed leader in the pharmaceutical industry. CPhI China offers a key access point to the second largest pharma market in the world. The exhibition features over 3,000 companies and incorporates various API showcases like bioLIVE, iCSE, NEX and FDF, creating a comprehensive platform that connects the entire pharmaceutical industry chain in the Asian-Pacific region.

  • 2022 CPhI Exhibition Shanghai

    CPhI is the undisputed leader in the pharmaceutical industry. CPhI China offers a key access point to the second largest pharma market in the world. The exhibition features over 3,000 companies and incorporates various API showcases like bioLIVE, iCSE, NEX and FDF, creating a comprehensive platform that connects the entire pharmaceutical industry chain in the Asian-Pacific region.

  • Welcome to CPhI JAPAN 2025

    CPhI JAPAN 2025 will be held at East Halls 6, Tokyo Big Sight from April 09-11,2025, our booth number is 6C-20a.

  • What are the categories of pharmaceutical intermediates?

    Pharmaceutical intermediates are classified by therapeutic areas, chemical structures, synthesis stages and production technologies, covering multiple types such as anti-tumor and anti-infection. They are key precursors in the synthesis of active pharmaceutical ingredients.

  • What Are Chemical Intermediates and How Are They Used in Pharmaceutical Manufacturing

    At Humanwell, our two decades of experience are dedicated to mastering these very compounds. We understand that the purity, stability, and reliability of every Intermediates Category directly determine the safety, efficacy, and scalability of the final drug. This blog will delve into the indispensable role these molecules play and how Humanwell ensures your manufacturing process is built on a foundation of excellence.

  • Meet Us at CPHI Japan 2026 – Booth 2K32

    We will attend CPHI Japan 2026 at Tokyo Big Sight from April 21 to 23, with booth 2K32.

Send Inquiry

  • E-mail
  • QR
Hit enter to search or ESC to close
X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept